Cefuroxime acetil crystalline

Readily available Recent EU registration dossier

Offer available for: licensing

Pharmaceutical form and dosage: 250-500 mg Tablets

Type:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic target:

- Infectious Diseases

Action: Antibiotics - systemic (anti-infectives)

Full Description:
Cefuroxime acetil crystalline dossier:
-New readily available for licensing
-Stability: 25°C: 18 months + continued, 40°C: 6 months.

Note: Amorphous dossier under development also available

Availability and Market information:

Status: Registered (MA obtained)

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- Germany
Registration info: On request: registration in other countries
BE Available

Market information

Other Market Info:

Patent Information:
Name: Zinnat
Patent expiration date: 2003
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.